These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30416068)

  • 1. Warnings for drug-drug interactions in consumer medication information provided by community pharmacies.
    Panich J; Gooden A; Shirazi FM; Malone DC
    J Am Pharm Assoc (2003); 2019; 59(1):35-42. PubMed ID: 30416068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of consumer medication information dispensed in retail pharmacies.
    Winterstein AG; Linden S; Lee AE; Fernandez EM; Kimberlin CL
    Arch Intern Med; 2010 Aug; 170(15):1317-24. PubMed ID: 20696955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of consumer medical information and oral liquid measuring devices accompanying pediatric prescriptions.
    Wallace LS; Keenum AJ; DeVoe JE
    Acad Pediatr; 2010; 10(4):224-7. PubMed ID: 20605545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consumer Medication Information: Similarities and Differences Between Three Canadian Pharmacies.
    Monkman H; Kushniruk AW
    Stud Health Technol Inform; 2017; 234():238-242. PubMed ID: 28186048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do medication samples jeopardize patient safety?
    Franks AS; Ray SM; Wallace LS; Keenum AJ; Weiss BD
    Ann Pharmacother; 2009 Jan; 43(1):51-6. PubMed ID: 19092144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expert and consumer evaluation of patient medication leaflets provided in U.S. pharmacies.
    Svarstad BL; Mount JK; Tabak ER
    J Am Pharm Assoc (2003); 2005; 45(4):443-51. PubMed ID: 16128499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All Consumer Medication Information Is Not Created Equal: Implications for Medication Safety.
    Monkman H; Kushniruk AW
    Stud Health Technol Inform; 2017; 234():233-237. PubMed ID: 28186047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. We Built It, But They Are Not Coming: Exploring Deterrents to Consumer Medication Information Use.
    Monkman H; Kushniruk AW; Barnett J; Borycki EM; Sheets D
    Stud Health Technol Inform; 2019 Aug; 265():189-194. PubMed ID: 31431597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of medication information available on retail pharmacy Web sites.
    Ghoshal M; Walji MF
    Res Social Adm Pharm; 2006 Dec; 2(4):479-98. PubMed ID: 17161807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consumer medication information in the United States, Europe, and Australia: a comparative evaluation.
    Raynor DK; Svarstad B; Knapp P; Aslani P; Rogers MB; Koo M; Krass I; Silcock J
    J Am Pharm Assoc (2003); 2007; 47(6):717-24. PubMed ID: 18032134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential drug-drug interactions in prescriptions dispensed in community pharmacies in Greece.
    Chatsisvili A; Sapounidis I; Pavlidou G; Zoumpouridou E; Karakousis VA; Spanakis M; Teperikidis L; Niopas I
    Pharm World Sci; 2010 Apr; 32(2):187-93. PubMed ID: 20077137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of Danish and Canadian Consumer Medication Information.
    Monkman H; Nøhr C; Kushniruk AW
    Stud Health Technol Inform; 2017; 241():147-152. PubMed ID: 28809198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the performance of drug-drug interaction screening software in community and hospital pharmacies.
    Abarca J; Colon LR; Wang VS; Malone DC; Murphy JE; Armstrong EP
    J Manag Care Pharm; 2006 Jun; 12(5):383-9. PubMed ID: 16792445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of written prescription information provided in community pharmacies: a study in eight states.
    Svarstad BL; Bultman DC; Mount JK; Tabak ER
    J Am Pharm Assoc (2003); 2003; 43(3):383-93. PubMed ID: 12836789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
    Malone DC; Abarca J; Skrepnek GH; Murphy JE; Armstrong EP; Grizzle AJ; Rehfeld RA; Woosley RL
    Med Care; 2007 May; 45(5):456-62. PubMed ID: 17446832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential determinants of drug-drug interaction associated dispensing in community pharmacies.
    Becker ML; Kallewaard M; Caspers PW; Schalekamp T; Stricker BH
    Drug Saf; 2005; 28(5):371-8. PubMed ID: 15853439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suitability and readability of consumer medical information accompanying prescription medication samples.
    Wallace LS; Keenum AJ; Roskos SE; Blake GH; Colwell ST; Weiss BD
    Patient Educ Couns; 2008 Mar; 70(3):420-5. PubMed ID: 18178363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extending FDA guidance to include consumer medication information (CMI) delivery on mobile devices.
    Sage A; Blalock SJ; Carpenter D
    Res Social Adm Pharm; 2017; 13(1):209-213. PubMed ID: 26868207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' use and perception of medication information leaflets.
    Nathan JP; Zerilli T; Cicero LA; Rosenberg JM
    Ann Pharmacother; 2007 May; 41(5):777-82. PubMed ID: 17405820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.